Farmax India Ltd. - Research Center
590094 FARMAXIND Group (T) BSE data
Results
Statement
More
Mar ' 17 |
Mar ' 16 |
Mar ' 15 |
Mar ' 14 |
Mar ' 13 |
Equity share capital
53.42 |
53.42 |
53.42 |
40.83 |
40.83 |
Share application money
Preference share capital
Reserves & surplus
-72.18 |
-69.42 |
-59.64 |
-61.56 |
-52.72 |
Secured loans
41.00 |
41.00 |
41.02 |
34.78 |
29.67 |
Unsecured loans
Total
22.24 |
25.00 |
34.81 |
14.05 |
17.78 |
Gross block
36.38 |
36.38 |
37.29 |
37.10 |
37.10 |
Less : revaluation reserve
Less : accumulated depreciation
19.32 |
18.01 |
17.22 |
15.05 |
13.11 |
Net block
10.02 |
11.34 |
13.04 |
15.02 |
16.95 |
Capital work-in-progress
Investments
Current assets, loans & advances
13.62 |
15.49 |
24.67 |
8.90 |
8.51 |
Less : current liabilities & provisions
Total net current assets
12.21 |
13.66 |
21.76 |
-0.97 |
0.83 |
Miscellaneous expenses not written
Total
22.24 |
25.00 |
34.81 |
14.05 |
17.78 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
5341.71 |
5341.71 |
5341.71 |
4083.00 |
4083.00 |